SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
29-Jan-24 5:44 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 832 | $48.30 | $40,185.60 | (2%) 43.97K to 43.14K | |
29-Jan-24 5:47 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 397 | $48.30 | $19,175.10 | (2%) 26.04K to 25.64K | |
29-Jan-24 5:42 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 25-Jan-24 | Private Sale | 2,527 | $48.30 | $122,054.00 | (1%) 174.3K to 171.77K | |
10-Jan-24 4:31 PM View: | Mario Ernest Director | Soleno Therapeutics Inc (SLNO) | 08-Jan-24 | Gift | 3,523 | -- | -- | (2%) 148.84K to 145.32K | |
08-Jan-24 5:35 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 24,000 | -- | -- | 120% 19.97K to 43.97K | |
08-Jan-24 5:37 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 24,000 | -- | -- | 1178% 2.04K to 26.04K | |
08-Jan-24 5:34 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 150,000 | -- | -- | 617% 24.3K to 174.3K | |
08-Jan-24 5:36 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 04-Jan-24 | Grant | 56,000 | -- | -- | 462% 12.13K to 68.13K | |
15-Dec-23 6:00 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 14-Dec-23 | Sale | 1,359 | $36.49 | $49,583.50 | (6%) 21.33K to 19.97K | |
14-Dec-23 7:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 13-Dec-23 | Sale | 13,333 | $37.76 | $503,490.00 | (87%) 15.37K to 2.04K | |
15-Dec-23 6:00 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 13-Dec-23 | Private Sale | 4,885 | $38.79 | $189,513.00 | (19%) 26.22K to 21.33K | |
14-Dec-23 7:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 13-Dec-23 | Option Exercise | 17,916 | $2.55 | $45,644.20 | 880% 2.04K to 19.95K | |
14-Dec-23 7:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 13-Dec-23 | Option Sale | 4,583 | $37.76 | $173,066.00 | (23%) 19.95K to 15.37K | |
14-Dec-23 7:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 12-Dec-23 | Sale | 6,580 | $36.95 | $243,160.00 | (76%) 8.62K to 2.04K | |
14-Dec-23 7:57 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 12-Dec-23 | Private Option Sale | 13,333 | $36.95 | $492,714.00 | (61%) 21.95K to 8.62K | |
13-Dec-23 9:34 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 11-Dec-23 | Option Sale | 15,000 | $36.41 | $546,223.00 | (34%) 44.61K to 29.61K | |
13-Dec-23 9:34 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 11-Dec-23 | Private Sale | 93,408 | $35.67 | $3,331,700.00 | (79%) 117.7K to 24.3K | |
13-Dec-23 9:34 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 11-Dec-23 | Sale | 17,482 | $36.41 | $636,605.00 | (59%) 29.61K to 12.13K | |
13-Dec-23 9:34 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 11-Dec-23 | Option Exercise | 15,000 | $2.60 | $38,925.00 | 51% 29.61K to 44.61K | |
04-Dec-23 8:03 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 30-Nov-23 | Private Sale | 3,823 | $28.65 | $109,536.00 | (13%) 30.04K to 26.22K | |
04-Dec-23 8:41 PM View: | Mario Ernest Director | Soleno Therapeutics Inc (SLNO) | 30-Nov-23 | Gift | 8,700 | -- | -- | (6%) 157.54K to 148.84K | |
04-Dec-23 8:06 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 30-Nov-23 | Private Sale | 3,963 | $28.65 | $113,547.00 | (15%) 25.91K to 21.95K | |
04-Dec-23 8:04 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 30-Nov-23 | Private Sale | 4,186 | $28.65 | $119,937.00 | (16%) 25.49K to 21.3K | |
04-Dec-23 8:02 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 30-Nov-23 | Private Sale | 27,716 | $28.65 | $794,116.00 | (20%) 135.78K to 108.06K | |
30-Nov-23 9:52 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 29-Nov-23 | Sale | 3,979 | $27.83 | $110,751.00 | (13%) 29.89K to 25.91K | |
30-Nov-23 9:52 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 29-Nov-23 | Sale | 4,203 | $27.83 | $116,986.00 | (14%) 29.69K to 25.49K | |
30-Nov-23 9:50 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 29-Nov-23 | Sale | 27,827 | $27.83 | $774,535.00 | (17%) 163.6K to 135.78K | |
30-Nov-23 9:51 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 29-Nov-23 | Sale | 3,839 | $27.83 | $106,855.00 | (11%) 33.88K to 30.04K | |
30-Nov-23 9:52 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 28-Nov-23 | Private Sale | 3,878 | $27.12 | $105,190.00 | (12%) 33.57K to 29.69K | |
30-Nov-23 9:50 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 28-Nov-23 | Private Sale | 25,678 | $27.12 | $696,514.00 | (14%) 189.28K to 163.6K | |
30-Nov-23 9:51 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 28-Nov-23 | Private Sale | 3,542 | $27.12 | $96,076.50 | (9%) 37.42K to 33.88K | |
30-Nov-23 9:52 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 28-Nov-23 | Private Sale | 3,671 | $27.12 | $99,575.40 | (11%) 33.56K to 29.89K | |
13-Dec-23 9:32 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 20-Oct-23 | Option Exercise | 9,643 | $3.16 | $30,500.30 | 5% 189.28K to 198.93K | |
13-Dec-23 9:32 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 02-Oct-23 | Option Exercise | 8,309 | $2.95 | $24,497.20 | 25% 33.57K to 41.88K | |
04-Oct-23 4:30 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 02-Oct-23 | Exercise (in-the money or at-the-money) | 5,215,000 | $2.50 | $13,037,500.00 | 163% 3.2M to 8.42M | |
02-Oct-23 10:00 PM View: | Carlyle Group L.P. 10% Owner | Soleno Therapeutics Inc (SLNO) | 28-Sep-23 | Conversion | 329,930 | $1.75 | $577,378.00 | 27% 1.2M to 1.53M | |
28-Sep-23 3:45 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 28-Sep-23 | Purchase | 250,000 | $20.00 | $5,000,000.00 | 9% 2.82M to 3.07M | |
28-Sep-23 3:45 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 26-Sep-23 | Purchase | 616,789 | $16.40 | $10,113,900.00 | 28% 2.21M to 2.82M | |
28-Sep-23 5:00 PM View: | Vivo Opportunity, LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 26-Sep-23 | Exercise (in-the money or at-the-money) | 3,203,090 | $1.75 | $5,605,410.00 | 100% 0 to 3.2M | |
06-Jun-23 4:16 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 06-Jun-23 | Purchase | 200 | $5.93 | $1,186.00 | < 1% 2.21M to 2.21M | |
06-Jun-23 4:16 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 05-Jun-23 | Purchase | 78,468 | $5.98 | $469,239.00 | 4% 2.13M to 2.21M | |
06-Jun-23 4:16 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 02-Jun-23 | Purchase | 64,630 | $5.93 | $383,256.00 | 3% 2.06M to 2.13M | |
01-Jun-23 5:41 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 01-Jun-23 | Purchase | 7,500 | $5.59 | $41,925.00 | < 1% 2.06M to 2.06M | |
01-Jun-23 5:41 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 31-May-23 | Purchase | 10,000 | $5.28 | $52,800.00 | < 1% 2.05M to 2.06M | |
01-Jun-23 5:41 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 30-May-23 | Purchase | 17,500 | $5.34 | $93,450.00 | < 1% 2.03M to 2.05M | |
26-May-23 6:28 PM View: | Hirano Patricia C See Remarks | Soleno Therapeutics Inc (SLNO) | 26-May-23 | Grant | 28,149 | -- | -- | 304% 9.27K to 37.42K | |
26-May-23 6:28 PM View: | MacKaness James H Chief Financial Officer | Soleno Therapeutics Inc (SLNO) | 26-May-23 | Grant | 29,084 | -- | -- | 648% 4.49K to 33.57K | |
26-May-23 6:39 PM View: | Yen Kristen See Remarks | Soleno Therapeutics Inc (SLNO) | 26-May-23 | Grant | 29,131 | -- | -- | 657% 4.43K to 33.56K | |
26-May-23 6:26 PM View: | Anish Bhatnagar Chief Executive Officer Director | Soleno Therapeutics Inc (SLNO) | 26-May-23 | Grant | 160,602 | -- | -- | 560% 28.68K to 189.28K | |
26-May-23 5:57 PM View: | Perceptive Advisors LLC 10% Owner | Soleno Therapeutics Inc (SLNO) | 26-May-23 | Purchase | 22,500 | $5.27 | $118,575.00 | 1% 2.01M to 2.03M |